Billigmann P W
Klinge Pharma GmbH, München.
Fortschr Med. 1991 Mar 30;109(9):213-6.
In an observational study, 6,299 patients suffering from arthrosis and other rheumatic diseases were treated by 1,258 physicians with coated tablets containing 400 mg or 600 mg ibuprofen (Ibuprofen Klinge 400/600) with a view to establish tolerance and the incidence of rare side effects. The data of a random sample of 500 patients revealed, depending upon the nature of the disease presenting, good to very good improvement of pain, swelling and impaired mobility. Only 3% of the patients reported side effects, 0.3% of which were allergic in nature. Only 0.8% of the patients terminated treatment. The care-providing physicians assessed the results as very good or good in 93.3% for efficacy, and 96.8% for tolerance.
在一项观察性研究中,1258名医生用含有400毫克或600毫克布洛芬(布洛芬克林格400/600)的包衣片剂对6299名患有关节炎和其他风湿性疾病的患者进行治疗,以确定耐受性和罕见副作用的发生率。对500名患者的随机样本数据显示,根据所患疾病的性质,疼痛、肿胀和活动能力受损情况有良好至非常好的改善。只有3%的患者报告有副作用,其中0.3%为过敏性质。只有0.8%的患者终止治疗。提供护理的医生对疗效的评估为非常好或良好的占93.3%,对耐受性的评估为非常好或良好的占96.8%。